Safety profile of remifentanil: A post-marketing study in Indonesia
Remifentanil is a novel short-acting μ-opioid receptor agonist. Hence, it can be used as an alternative to fentanyl with additional short-acting potential. However, the safety profile of remifentanil in the Indonesian population through post-marketing surveillance has not been evaluated yet. Therefo...
| Hauptverfasser: | , , , , , , |
|---|---|
| Format: | Artikel |
| Sprache: | English |
| Veröffentlicht: |
Open Science Publishers LLP
2022
|
| Schlagworte: | |
| Online Zugang: | https://repository.ugm.ac.id/283444/1/Jarir%20At%20Thobari_Safety%20profile%20of%20remifentanil.pdf |